Get the Daily Brief
Latest Biotech News
Innovative magnetic soft millirobot with sensing capabilities
A research team led by W. Zeng and colleagues has developed a millimeter-scale magnetic soft robot capable of simultaneous locomotion and environmental sensing. Published in npj Flexible...
Parkinson’s disease insights from perivascular fluid and nerve fibers
Recent studies underscore novel biomarkers and pathological features in Parkinson’s disease and atypical parkinsonism. One cohort study, published in npj Parkinson’s Disease, identified...
Advances in solid-state nanopore sensors for DNA sequencing
Researchers at the University of Illinois Urbana-Champaign engineered a novel solid-state nanopore platform using 2D materials, advancing label-free single-biomolecule detection technology....
AI-generated podcasts redefine science communication
A study led by Professor Philip Moons demonstrated the capability of AI, using Google NotebookLM, to produce podcasts summarizing scientific research effectively. The AI-generated content received...
European Moveo project launches smart transport innovations
The MOVEO project officially launched in Málaga, Spain, brings together 16 partners from nine countries to develop sustainable, integrated transport solutions across Europe. Funded by Horizon...
Pharma reforms and challenges in US budget bill
The extensive US budget bill under Senate consideration includes significant changes impacting pharma, including reform proposals for the Inflation Reduction Act’s Medicare drug price negotiation...
23andMe sold to Anne Wojcicki's nonprofit amid bidding war
Genetic testing firm 23andMe agreed to be acquired by a nonprofit led by co-founder Anne Wojcicki for $305 million, prevailing in a final bidding round over Regeneron. This transaction concludes a...
Emerging PD-1 x IL-2 antibody fusions in cancer therapy
Innovent Biologics advances their PD-1 × IL-2 antibody fusion IBI363 into registrational studies after demonstrating Phase I/II efficacy across three cold tumor types. This bispecific approach...
Sarepta Halts Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatality caused by acute liver failure. Both...
Anne Wojcicki's Nonprofit Wins 23andMe Asset Auction at $305M
Anne Wojcicki, co-founder and ex-CEO of 23andMe, has prevailed in a bankruptcy auction for the company's assets by bidding $305 million through her nonprofit TTAM Research Institute. This offer...
FDA Approves Pembrolizumab for Resectable Head and Neck Cancer
The FDA has approved pembrolizumab, an immune checkpoint inhibitor, for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS≥1). Approval was based...
Breakthroughs in Parkinson’s Disease Biomarkers and Pathology
Recent studies have uncovered novel insights into Parkinson’s disease pathology and progression. Researchers identified changes in cutaneous nerve fibers linked to Parkinson’s and atypical...
Advances in Nanopore and Soft Robotics Technologies
Engineering innovations include a novel solid-state nanopore sensing platform developed by University of Illinois researchers enabling label-free single-biomolecule detection, enhancing prospects...
Silver Anniversary Reflections on the Human Genome Project
The 25-year milestone of the Human Genome Project's first draft is marked by reflections from key figures, including Francis Collins and J. Craig Venter. Their insights highlight the...
Multiomics Proteomics Partnerships Accelerate Integrated Biology
The proteomics field is witnessing strategic partnerships aligning gene sequencing with advanced protein analysis technologies. Ultima Genomics collaborates with Olink Proteomics, leveraging...
FDA and Pharma Strategic Leadership and Regulatory Updates
Bristol Myers Squibb appoints Chris Shibutani, M.D., a former Goldman Sachs biotech analyst and practicing anesthesiologist, as EVP and Chief Strategy Officer to guide long-term strategy and...
Emerging Biotech Research and Innovation Highlights
Promising research spans biomaterial development to reverse heart aging by modulating extracellular matrix properties, and drone technology equipped with AI gas sensors to enable rapid detection...
Significant Biopharma Financing and Market Trends
Year-to-date biopharma financing continues robustly with significant funds raised in both public and private rounds, reflecting sustained investor interest despite industry layoffs. Market...
Sarepta halts Duchenne gene therapy amid patient deaths
Sarepta Therapeutics has suspended Elevidys shipments for non-ambulatory Duchenne muscular dystrophy patients following a second acute liver failure death. Both fatalities involved boys reliant on...
Anne Wojcicki’s nonprofit outbids Regeneron for 23andMe
Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, has won a bidding war to purchase most of 23andMe’s assets for $305 million. This new agreement...